Edwards Lifesciences (EW) Is At $141.34 Formed Wedge; MX GOLD ORDINARY SHARES (MXLGF) Shorts Down By 92.59%

Edwards Lifesciences Corporation (NYSE:EW) Logo

Edwards Lifesciences Corporation (EW) formed wedge up with $151.23 target or 7.00% above today’s $141.34 share price. Edwards Lifesciences Corporation (EW) has $29.76B valuation. The stock increased 1.86% or $2.58 during the last trading session, reaching $141.34. About 730,996 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 44.06% since April 5, 2017 and is uptrending. It has outperformed by 32.51% the S&P500.

MX GOLD CORP ORDINARY SHARES (OTCMKTS:MXLGF) had a decrease of 92.59% in short interest. MXLGF’s SI was 2,800 shares in April as released by FINRA. Its down 92.59% from 37,800 shares previously. The stock increased 27.66% or $0.01 during the last trading session, reaching $0.03. About 27,100 shares traded. MX Gold Corp. (OTCMKTS:MXLGF) has 0.00% since April 5, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 28 analysts covering Edwards Lifesciences Corp (NYSE:EW), 22 have Buy rating, 1 Sell and 5 Hold. Therefore 79% are positive. Edwards Lifesciences Corp had 108 analyst reports since July 30, 2015 according to SRatingsIntel. Canaccord Genuity maintained Edwards Lifesciences Corporation (NYSE:EW) on Thursday, February 1 with “Buy” rating. The stock of Edwards Lifesciences Corporation (NYSE:EW) earned “Hold” rating by Deutsche Bank on Thursday, October 26. BMO Capital Markets maintained the shares of EW in report on Thursday, August 31 with “Buy” rating. BMO Capital Markets maintained Edwards Lifesciences Corporation (NYSE:EW) on Thursday, February 1 with “Buy” rating. Jefferies maintained it with “Buy” rating and $11500 target in Thursday, June 29 report. Nomura initiated Edwards Lifesciences Corporation (NYSE:EW) on Thursday, March 17 with “Buy” rating. The stock of Edwards Lifesciences Corporation (NYSE:EW) earned “Buy” rating by RBC Capital Markets on Monday, July 10. Cowen & Co maintained it with “Buy” rating and $165.0 target in Tuesday, March 20 report. Canaccord Genuity maintained the stock with “Buy” rating in Thursday, July 27 report. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Equalweight” rating given on Wednesday, July 27 by Barclays Capital.

Analysts await Edwards Lifesciences Corporation (NYSE:EW) to report earnings on April, 24. They expect $1.10 earnings per share, up 17.02% or $0.16 from last year’s $0.94 per share. EW’s profit will be $231.57M for 32.12 P/E if the $1.10 EPS becomes a reality. After $0.94 actual earnings per share reported by Edwards Lifesciences Corporation for the previous quarter, Wall Street now forecasts 17.02% EPS growth.

MX Gold Corp., a natural resource company, engages in the acquisition, exploration, and development of mining properties in Canada. The company has market cap of $23.96 million. The firm explores for gold, copper, and silver deposits. It currently has negative earnings. It primarily holds a 100% interest in the Willa property with 21 mineral claims covering a surface area of approximately 5,329 hectares located in the Slocan mining division, British Columbia.

Edwards Lifesciences Corporation (NYSE:EW) Ratings Chart